MedPath

A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

Phase 4
Conditions
Coronary Artery Disease
Interventions
Drug: Placebo
Drug: Heart-protecting Musk Pill
Registration Number
NCT01897805
Lead Sponsor
Shanghai Hutchison Pharmaceuticals Limited
Brief Summary

Title:

A randomized, double-blind, multi-centered, placebo-controlled trial to examine effects of of Heart-protecting Musk Pill on clinical outcomes in patients with chronic stable coronary artery disease

Objective:

To examine effects of of Heart-protecting Musk Pill, a traditional Chinese medicine, on clinical outcomes in patients with chronic stable coronary artery disease

The study hypothesis:

The null hypothesis: the combined incidence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke in the treatment group is the same as that in control group.

The alternative hypothesis: the combined incidence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke in the treatment group is different from that in control group.

Sample size:

2700 patients will be randomized, 1350 in treatment group and 1350 in placebo group.

Number of sites: 99 sites in China

Study drugs:

Heart-protecting Musk Pill and the matching placebo pills.

Design:

A randomized, double-blind, multi-centered, placebo-controlled trial. Patients will be randomized to treatment group and placebo group after screening and get corresponding treatment as follow.

Treatment group: Standard treatment for coronary artery disease plus 2 Heart-protecting Musk Pills each time, three times a day by mouth for 24 months.

Control group: Standard treatment for coronary artery disease plus 2 placebo pills each time, three times a day by mouth for 24 months.

Patients will be followed up at baseline, 1, 3, 6, 9, 12, 18, 24 months after randomization. During follow-up period, patients could undertake PCI or CABG if angina get out of control or evidence of ischemia aggravated is found.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2700
Inclusion Criteria
  1. Age≥18 years at screening.
  2. Patients who have ischemia myocardial symptoms and whose clinical symptoms keep stable for at least one month.
  3. Have at least one of the following events (providing hospital records or inspection report): 1)history of acute myocardial infarction for at least half of a year; 2) history of PCI or CABG for at least half of a year; 3) coronary CT angiography or coronary angiography shows that at least one of the main branches of coronary artery stenosis is no less than 50%.
  4. Provide informed consent form.
Exclusion Criteria
  1. History of acute myocardial infarction, vascular reconstruction, CABG or PCI within half of a year.
  2. Prepared to undertake CABG or PCI during this study.
  3. Serious cardiovascular diseases: sustained severe angina (CCS Ⅳ), refractory heart failure, cardiogenic shock, severe aortic stenosis or aortic insufficiency.
  4. Severe respiratory diseases;
  5. Diabetic patients with poor glycemic control (fasting blood glucose > 200 mg/dl or 11.1mmol/L for more than twice within one month before the study entry).
  6. Hypertensive patients with poor control of blood pressure, systolic pressure≥180mmHg or diastolic pressure≥110mmHg before entry.
  7. Severe liver and kidney diseases,such as active liver disease, cirrhosis and uremia.
  8. Any other severe diseases, such as malignant tumor, severe anemia and severe renal artery stenosis.
  9. Unable or unwilling to sign informed consent form.
  10. Join another trial or has received random allocation of this study within one month before entry.
  11. Pregnant or who were attempting to become pregnant.
  12. Patients who are regarded as not being suitable participants by the study investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPatients will get standard treatment for coronary artery disease plus 2 placebo pills each time, three times a day by mouth for 24 months
Heart-protecting Musk PillHeart-protecting Musk PillPatients will get standard treatment for coronary artery disease plus 2 Heart-protecting Musk Pills each time, three times a day by mouth for 24 months
Primary Outcome Measures
NameTimeMethod
The combined incidence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke24 months
Secondary Outcome Measures
NameTimeMethod
The combined incidence of all-cause mortality, nonfatal myocardial infarction, nonfatal stroke, hospitalization for unstable angina or heart failure, and peripheral revascularization (PCI or CABG)24 months

Trial Locations

Locations (98)

ShenZhen People's Hospital

🇨🇳

Shenzhen, Guangdong, China

The First People's Hospital of Liuzhou City

🇨🇳

Liuzhou, Guangxi, China

The First Affiliated Hospital Of GuangXi University Of Chinese Medicine

🇨🇳

Nanning, Guangxi, China

HeBei General Hosital

🇨🇳

Shijiazhuang, Hebei, China

DaQing General Hospial Group LongNan Hosptial

🇨🇳

Daqing, Heilongjiang, China

KaiFeng Central Hospital

🇨🇳

Kaifeng, Henan, China

People's Hospital of Henan Province

🇨🇳

Zhengzhou, Henan, China

SuZhou Municipal Hospital

🇨🇳

Suzhou, Jiangsu, China

AnHui Provincial Hospital

🇨🇳

Hefei, Anhui, China

The First Affiliated Hospital of Medical University Of Anhui

🇨🇳

Hefei, Anhui, China

Beijing Tongren Hospital Capital Medical University

🇨🇳

Beijing, Beijing, China

Navi General Hospital

🇨🇳

Beijing, Beijing, China

Dongfang Hospital Affiliated to Beijing University of Chinese Medicine

🇨🇳

Beijing, Beijing, China

The Seond Hospital of HeBei Medical University

🇨🇳

Shijiazhuang, Hebei, China

The Second Affiliated Hospital of Henan University of TCM

🇨🇳

Zhengzhou, Henan, China

Hubei Provincial Corps Hospital of CPAPF

🇨🇳

Wuhan, Hubei, China

The First Affiliated Hospital of University of South China

🇨🇳

Hengyang, Hunan, China

JiangSu Province Hosptial of TCM

🇨🇳

Nanjing, Jiangsu, China

JiangSu TaiZhou People's Hospital

🇨🇳

Taizhou, Jiangsu, China

JiangSu Province Hosptial

🇨🇳

Nanjing, Jiangsu, China

NanJing Hospital of TCM

🇨🇳

Nanjing, Jiangsu, China

The First Hospital of NanChang

🇨🇳

Nanchang, Jiangxi, China

Northern JiangSu People's Hospital

🇨🇳

Yangzhou, Jiangsu, China

China-Japan Union Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

The First Hospital Of China Medical University

🇨🇳

Anshan, Liaoning, China

The 210th Hospital of Chinese people's Liberation Army

🇨🇳

Dalian, Liaoning, China

The second people's Hospital of Dalian

🇨🇳

Dalian, Liaoning, China

The Fourth Affiliated Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

Affiliated Hospital of Shandong University of TCM

🇨🇳

Jinan, Shandong, China

Shangdong Provincial Hospital

🇨🇳

Jinan, Shandong, China

Linyi People's Hospital

🇨🇳

Linyi, Shandong, China

Qingdao University Medical College Affiliated Yuhuangding Hospital

🇨🇳

Qingdao, Shandong, China

Qilu Hospital of Shandong University

🇨🇳

Qinan, Shandong, China

Huadong Hospital Affiliated To Fudan University

🇨🇳

Shanghai, Shanghai, China

Shanghai First People's Hospital

🇨🇳

Shanghai, Shanghai, China

Shanghai East Hospital

🇨🇳

Shanghai, Shanghai, China

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Shuguang Hospital

🇨🇳

Shanghai, Shanghai, China

Tongji Hospital Affiliated to Tongji University

🇨🇳

Shanghai, Shanghai, China

Shanxi Medical University First Hospital

🇨🇳

Taiyuan, Shanxi, China

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Zhongshan hospital Fudan University

🇨🇳

Shanghai, Shanghai, China

Shanxi Medical University Second Hospital

🇨🇳

Taiyuan, Shanxi, China

Sichuan Provincial People's Hospital

🇨🇳

Chengdu, Sichuan, China

TianJin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

The Affiliated Hospital of Luzhou Medical College

🇨🇳

Luzhou, Sichuan, China

Yunnan Provincial Hospital of Traditional Chinese Medicine

🇨🇳

Kunming, Yunnan, China

Tianjin Third Central Hospital

🇨🇳

Tianjin, Tianjin, China

First People's Hospital of Yunnan Province

🇨🇳

Kunming, Yunnan, China

The Affiliated Hospital of Hangzhou Normal University

🇨🇳

Hangzhou, Zhejiang, China

The First Affiliated Hospital ZheJiang University

🇨🇳

Hangzhou, Zhejiang, China

Hangzhou Traditional Chinese Medical Hospital

🇨🇳

Hangzhou, Zhejiang, China

ZheJiang Hospital

🇨🇳

Hangzhou, Zhejiang, China

Tongde Hospital of ZheJiang Province

🇨🇳

Hangzhou, Zhejiang, China

Ningbo Medical Treatment Center of LiHuiLi Hospital

🇨🇳

Ningbo, Zhejiang, China

Zhejiang Provincial Hospital of TCM

🇨🇳

Hangzhou, Zhejiang, China

The Second Hospital Affiliated to Wenzhou Medical College

🇨🇳

Wenzhou, Zhejiang, China

Armed police Chongqing Corps Hospital

🇨🇳

Chongqing, Chongqing, China

Beijing Hospital

🇨🇳

Beijing, Beijing, China

The Third People's Hospital of Chongqing

🇨🇳

Chongqing, Chongqing, China

XiaMen Heart Center

🇨🇳

Xiamen, Fujian, China

Beijing An Zhen Hospital of the Capital University of Medical Sciences

🇨🇳

Beijing, Beijing, China

Beijing Shijitan Hospital

🇨🇳

Beijing, Beijing, China

MaAnShan Central Hospital

🇨🇳

Maanshan, Anhui, China

FuJian Provincial Hospital

🇨🇳

Fuzhou, Fujian, China

The People's Hospital of Jiangmen

🇨🇳

Jiangmen, Guangdong, China

Affiliated Hospital of Guangzhou Medcal College

🇨🇳

Guangzhou, Guangdong, China

The Affiliated Hospital of PuTian University

🇨🇳

Putian, Fujian, China

The Affiliated Hospital of Guangdong Medical College

🇨🇳

Zhanjiang, Guangdong, China

TangShan GongRen Hospital

🇨🇳

Tangshan, Hebei, China

The Second Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

People's Hospital of Fujian Province

🇨🇳

Fuzhou, Fujian, China

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

The First Affiliated Hospital of Henan University of TCM

🇨🇳

Zhengzhou, Henan, China

The First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

Taihe Hospital

🇨🇳

Shiyan, Hubei, China

Xiangyang Central Hospital

🇨🇳

Xiangyang, Hubei, China

The First People's Hospital of Changde

🇨🇳

Changde, Hunan, China

The Second Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

Xiangya Hospital Central-South University

🇨🇳

Changsha, Hunan, China

Renmin Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

Zhongnan Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

NanJing Drum Tower Hospital The Affiliated Hospital of NanJing University Medical School

🇨🇳

Nanjing, Jiangsu, China

WuXi People's Hospital

🇨🇳

Wuxi, Jiangsu, China

The Affiliated Hospital of XuZhou Medical College

🇨🇳

Xuzhou, Jiangsu, China

YangZhou No. 1 People's Hospital

🇨🇳

Yangzhou, Jiangsu, China

The Affiliated Hospital of JiangXi University of Traditional Chinese Medicine

🇨🇳

Nanchang, Jiangxi, China

The Second Affiliated Hospital of NanChang University

🇨🇳

Nanchang, Jiangxi, China

The Affiliated Hospital of Medical College of Qingdao University

🇨🇳

Yantai, Shandong, China

Huashan Hospital Fudan University

🇨🇳

Shanghai, Shanghai, China

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

🇨🇳

Shenyang, Liaoning, China

Affiliated Hospital of Chuanbei Medical College

🇨🇳

Nanchong, Sichuan, China

TianHe Hospital

🇨🇳

Tianjin, Tianjin, China

The First Teaching Hospital of TianJin University of Traditional Chinese Medicine

🇨🇳

Tianjin, Tianjin, China

Ningbo First Hospital

🇨🇳

Ningbo, Zhejiang, China

NanJing First Hospital

🇨🇳

Nanjing, Jiangsu, China

Peking University First Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath